Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis.
18F-FDG PET/CT in Tumefactive Multiple Sclerosis.
Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.
Deliberate Fingolimod Overdose Presenting with Delayed Hypotension and Bradycardia Responsive to Atropine.
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Whole-Brain In-vivo Measurements of the Axonal G-Ratio in a Group of 37 Healthy Volunteers.
Perceptions of health status in multiple sclerosis patients and their doctors.
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.
Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Oral laquinimod for multiple sclerosis.
Assay selection affects John Cunningham virus serostatus classification in multiple sclerosis.
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures.
Obesity in autoimmune diseases: Not a passive bystander.
Schwann cells in therapy of spinal cord injuries.
Teva targets $4 billion lupus market with laquinimod study
Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.
Neuromyelitis Optica Preceded by HyperCKemia and a Possible Association with Coxsackie Virus Group A10 Infection.
Building an RNA Sequencing Transcriptome of the Central Nervous System.
Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica.
The common marmoset as a novel animal model system for biomedical and neuroscience research applications.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.
Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease.
Clinical designs of recent robot rehabilitation trials.
Expansion of CD27(high) plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.
More than just multiple sclerosis.
Pages
« first
‹ previous
…
273
274
275
276
277
278
279
280
281
…
next ›
last »